| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;114:1616-1624.)
© 2006 American Heart Association, Inc.
Valvular Heart Disease |
From the HELIOS Heart Center Siegburg, Departments of Cardiology (E.G., U.G., L.B., R.M., M.M., T.S.), Cardiac Surgery (T.F., S.I.), and Anesthesiology (B.S., B.Z.), Siegburg, Germany; Clinique Pasteur, Toulouse, France (J.C.L.); and Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.).
Correspondence to Eberhard Grube, MD, Department of Cardiology/Angiology, HELIOS Heart Center Siegburg, Ringstrasse 49, 53721 Siegburg, Germany. E-mail GrubeE{at}aol.com
Received May 10, 2006; revision received August 11, 2006; accepted August 14, 2006.
Background The morbidity and mortality of surgical aortic valve replacement are increased in elderly patients with multiple high-risk comorbid conditions. Therefore, a prospective, single-center, nonrandomized study was performed in high-risk patients with aortic valve disease to evaluate the feasibility and safety of percutaneous implantation of a novel self-expanding aortic valve bioprosthesis (CoreValve).
Methods and Results Symptomatic high-risk patients with an aortic valve area <1 cm2 were considered for enrollment. CoreValve implantation was performed under general anesthesia with extracorporeal support using the retrograde approach. Clinical follow-up and transthoracic echocardiography were performed after the procedure and at days 15 and 30 after device implantation to evaluate short-term patient and device outcomes. A total of 25 patients with symptomatic aortic valve stenosis (mean gradient before implantation, 44.2±10.8 mm Hg) and multiple comorbidities (median logistic EuroScore, 11.0%) were enrolled. Device success and procedural success were achieved in 22 (88%) and 21 (84%) patients, respectively. Successful device implantation resulted in a marked reduction in the aortic valve gradients (mean gradient after implantation, 12.4±3.0 mm Hg; P<0.0001). The mean aortic regurgitation grade was unchanged. Major in-hospital cardiovascular and cerebral events occurred in 8 patients (32%), including mortality in 5 patients (20%). Among 18 patients with device success surviving to discharge, no adverse events occurred within 30 days after leaving the hospital.
Conclusions Percutaneous implantation of the self-expanding CoreValve aortic valve prosthesis in high-risk patients with aortic stenosis with or without aortic regurgitation is feasible and, when successful, results in marked hemodynamic and clinical improvement.
This article has been cited by other articles:
![]() |
D. Himbert, F. Descoutures, N. Al-Attar, B. Iung, G. Ducrocq, D. Detaint, E. Brochet, D. Messika-Zeitoun, F. Francis, H. Ibrahim, et al. Results of Transfemoral or Transapical Aortic Valve Implantation Following a Uniform Assessment in High-Risk Patients With Aortic Stenosis J. Am. Coll. Cardiol., July 21, 2009; 54(4): 303 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Aregger, P. Wenaweser, G. J. Hellige, A. Kadner, T. Carrel, S. Windecker, and F. J. Frey Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2175 - 2179. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Schoenhagen, E. M. Tuzcu, S. R. Kapadia, M. Y. Desai, and L. G. Svensson Three-dimensional imaging of the aortic valve and aortic root with computed tomography: new standards in an era of transcatheter valve repair/implantation Eur. Heart J., June 27, 2009; (2009) ehp260v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Webb, L. Altwegg, R. H. Boone, A. Cheung, J. Ye, S. Lichtenstein, M. Lee, J. B. Masson, C. Thompson, R. Moss, et al. Transcatheter Aortic Valve Implantation: Impact on Clinical and Valve-Related Outcomes Circulation, June 16, 2009; 119(23): 3009 - 3016. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Al-Attar, D. Himbert, F. Descoutures, B. Iung, R. Raffoul, D. Messika-Zeitoun, E. Brochet, F. Francis, H. Ibrahim, A. Vahanian, et al. Transcatheter Aortic Valve Implantation: Selection Strategy Is Crucial for Outcome. Ann. Thorac. Surg., June 1, 2009; 87(6): 1757 - 1763. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Kapadia, S. S. Goel, L. Svensson, E. Roselli, R. M. Savage, L. Wallace, S. Sola, P. Schoenhagen, M. H. Shishehbor, R. Christofferson, et al. Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement. J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1430 - 1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zajarias and A. G. Cribier Outcomes and Safety of Percutaneous Aortic Valve Replacement J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1829 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kurra, P. Schoenhagen, E. E. Roselli, S. R. Kapadia, E. M. Tuzcu, R. Greenberg, M. Akhtar, M. Y. Desai, S. D. Flamm, S. S. Halliburton, et al. Prevalence of significant peripheral artery disease in patients evaluated for percutaneous aortic valve insertion: Preprocedural assessment with multidetector computed tomography. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1258 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Suzuki, A. C. Yeung, and F. Ikeno The Pre-Clinical Animal Model in the Translational Research of Interventional Cardiology J. Am. Coll. Cardiol. Intv., May 1, 2009; 2(5): 373 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Balzer, M. Kelm, and H. P. Kuhl Real-time three-dimensional transoesophageal echocardiography for guidance of non-coronary interventions in the catheter laboratory Eur J Echocardiogr, May 1, 2009; 10(3): 341 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bleiziffer, H. Ruge, D. Mazzitelli, C. Schreiber, A. Hutter, J.-C. Laborde, R. Bauernschmitt, and R. Lange Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 615 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wendt, W. Muller, F. Hauck, M. Thielmann, H. Wendt, B. Kipfmuller, B. Vogel, and H. Jakob In vitro results of a new minimally invasive aortic valve resecting tool Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 622 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W.A. van Geldorp, W.R. Eric Jamieson, A. P. Kappetein, J. Ye, G. J. Fradet, M. J.C. Eijkemans, G. L. Grunkemeier, A. J.J.C. Bogers, and J. J.M. Takkenberg Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: Weighing lifetime anticoagulant-related event risk against reoperation risk J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 881 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Delgado, L. F. Tops, J. D. Schuijf, F. van der Kley, N. R. van de Veire, M. J. Schalij, and J. J. Bax Successful Deployment of a Transcatheter Aortic Valve in Bicuspid Aortic Stenosis: Role of Imaging With Multislice Computed Tomography Circ Cardiovasc Imaging, March 1, 2009; 2(2): e12 - e13. [Full Text] [PDF] |
||||
![]() |
R D Christofferson, S R Kapadia, V Rajagopal, and E M Tuzcu Emerging transcatheter therapies for aortic and mitral disease Heart, January 15, 2009; 95(2): 148 - 155. [Full Text] [PDF] |
||||
![]() |
M. Napodano, G. Tarantini, and A. Ramondo Is it reasonable to treat all calcified stenotic valves with a valve stent? Probably yes if we get a full stent expansion. J. Am. Coll. Cardiol., January 13, 2009; 53(2): 219 - 219. [Full Text] [PDF] |
||||
![]() |
D. Chin Echocardiography for transcatheter aortic valve implantation Eur J Echocardiogr, January 1, 2009; 10(1): i21 - i29. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vahanian, O. R. Alfieri, N. Al-Attar, M. J. Antunes, J. Bax, B. Cormier, A. Cribier, P. De Jaegere, G. Fournial, A. P. Kappetein, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 1 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Svensson, T. Dewey, S. Kapadia, E. E. Roselli, A. Stewart, M. Williams, W. N. Anderson, D. Brown, M. Leon, B. Lytle, et al. United States Feasibility Study of Transcatheter Insertion of a Stented Aortic Valve by the Left Ventricular Apex Ann. Thorac. Surg., July 1, 2008; 86(1): 46 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Descoutures, D. Himbert, L. Lepage, B. Iung, D. Detaint, D. Tchetche, E. Brochet, Y. Castier, J.-P. Depoix, P. Nataf, et al. Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly Eur. Heart J., June 1, 2008; 29(11): 1410 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vahanian, O. Alfieri, N. Al-Attar, M. Antunes, J. Bax, B. Cormier, A. Cribier, P. De Jaegere, G. Fournial, A. P. Kappetein, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur. Heart J., June 1, 2008; 29(11): 1463 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Tops, D. A. Wood, V. Delgado, J. D. Schuijf, J. R. Mayo, S. Pasupati, F. P.L. Lamers, E. E. van der Wall, M. J. Schalij, J. G. Webb, et al. Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. J. Am. Coll. Cardiol. Img., May 1, 2008; 1(3): 321 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Quaden, T. Attmann, M. Schunke, D. Theisen-Kunde, J. Cremer, and G. Lutter Percutaneous aortic valve replacement: Endovascular resection of human aortic valves in situ. J. Thorac. Cardiovasc. Surg., May 1, 2008; 135(5): 1081 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Webb Percutaneous Aortic Valve Replacement Will Become a Common Treatment for Aortic Valve Disease J. Am. Coll. Cardiol. Intv., April 1, 2008; 1(2): 122 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Rosengart, T. Feldman, M. A. Borger, T. A. Vassiliades Jr, A. M. Gillinov, K. J. Hoercher, A. Vahanian, R. O. Bonow, and W. O'Neill Percutaneous and Minimally Invasive Valve Procedures: A Scientific Statement From the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation, April 1, 2008; 117(13): 1750 - 1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zegdi, V. Ciobotaru, M. Noghin, G. Sleilaty, A. Lafont, C. Latremouille, A. Deloche, and J.-N. Fabiani Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J. Am. Coll. Cardiol., February 5, 2008; 51(5): 579 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zegdi, G. Sleilaty, A. Lafont, and J.-N. Fabiani Percutaneous Aortic Valve Replacement With the CoreValve Prosthesis J. Am. Coll. Cardiol., January 15, 2008; 51(2): 170 - 170. [Full Text] [PDF] |
||||
![]() |
E. A. Grossi, C. F. Schwartz, P.-J. Yu, U. P. Jorde, G. A. Crooke, J. B. Grau, G. H. Ribakove, F. G. Baumann, P. Ursumanno, A. T. Culliford, et al. High-Risk Aortic Valve Replacement: Are the Outcomes as Bad as Predicted? Ann. Thorac. Surg., January 1, 2008; 85(1): 102 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Davidson and D. S. Baim Percutaneous Aortic Valve Interventions Card. Surg. Adult, January 1, 2008; 3(2008): 963 - 971. [Full Text] |
||||
![]() |
T. Feldman and M. B. Leon Prospects for Percutaneous Valve Therapies Circulation, December 11, 2007; 116(24): 2866 - 2877. [Full Text] [PDF] |
||||
![]() |
B. Qizilbash, P. Couture, and A. Denault Impact of Perioperative Transesophageal Echocardiography in Aortic Valve Replacement Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2007; 11(4): 288 - 300. [Abstract] [PDF] |
||||
![]() |
S. H. Goldbarg, S. Elmariah, M. A. Miller, and V. Fuster Insights Into Degenerative Aortic Valve Disease J. Am. Coll. Cardiol., September 25, 2007; 50(13): 1205 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walther, P. Simon, T. Dewey, G. Wimmer-Greinecker, V. Falk, M. T. Kasimir, M. Doss, M. A. Borger, G. Schuler, D. Glogar, et al. Transapical Minimally Invasive Aortic Valve Implantation: Multicenter Experience Circulation, September 11, 2007; 116(11_suppl): I-240 - I-245. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Dixon, C. L. Grines, and W. W. O'Neill The Year in Interventional Cardiology J. Am. Coll. Cardiol., July 17, 2007; 50(3): 270 - 285. [Full Text] [PDF] |
||||
![]() |
E. Grube, G. Schuler, L. Buellesfeld, U. Gerckens, A. Linke, P. Wenaweser, B. Sauren, F.-W. Mohr, T. Walther, B. Zickmann, et al. Percutaneous Aortic Valve Replacement for Severe Aortic Stenosis in High-Risk Patients Using the Second- and Current Third-Generation Self-Expanding CoreValve Prosthesis: Device Success and 30-Day Clinical Outcome J. Am. Coll. Cardiol., July 3, 2007; 50(1): 69 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walther, V. Falk, T. Dewey, J. Kempfert, F. Emrich, B. Pfannmuller, P. Broske, M. A. Borger, G. Schuler, M. Mack, et al. Valve-in-a-Valve Concept for Transcatheter Minimally Invasive Repeat Xenograft Implantation J. Am. Coll. Cardiol., July 3, 2007; 50(1): 56 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Grover, J. E. Mayer Jr, N. Kouchoukos, R. Guyton, F. Edwards, and J. Bavaria Letter by Grover et al Regarding Article, "Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study" Circulation, June 5, 2007; 115(22): e612 - e612. [Full Text] [PDF] |
||||
![]() |
E. Grube, L. Buellesfeld, U. Gerckens, R. Mueller, M. Menichelli, T. Schmidt, J. C. Laborde, T. Felderhoff, S. Iversen, B. Sauren, et al. Response to Letter Regarding Article, "Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study" Circulation, June 5, 2007; 115(22): e613 - e613. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |